当前位置: 首页 > 期刊 > 《中国当代医药》 > 2012年第5期 > 正文
编号:12191144
艾司西酞普兰治疗儿童青少年抑郁症的临床研究(3)
http://www.100md.com 2012年2月15日 王力芳 余炯枚 丁琰 贾美香
第1页

    参见附件。

     [10] Wade A,Friis Anderson H.The onset fo effect of effect for escitalopram and its releveance for the clinical management of depression[J].Current Medical Research and Opinion,2006,22(11):2101-2110.

    [11] Signorovitch J,Ramakrishnan K,Ben-HamadiR,et al.Remission of major depressive disorder without adverse events:a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors[J].Curr Med Res Opin,2011,27(6):1086-1096.

    [12] Wade AG,Crawford GM,Yellowlees A.Efficacy,safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder(MDD):an open-label,pilot study[J].BMC Psychiatry,2011,11:42.

    [13] Kennedy SH,Andersen HF,Lam RW.Efficacy of escitalopram in theatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR:a recta-analysis[J].J Psychiatry Neurosci,2006,31(4):228.

    [14] 梁月竹,周福春,郑毅,等.艾司西酞普兰治疗儿童青少年抑郁障碍临床研究[J].临床心身疾病杂志,2008,14(5):385-386.

    [15] 戴红,宋宝华.艾司西酞普兰治疗青少年首发性抑郁症的临床研究[J].齐齐哈尔医学院学报,2010,31(18):2876-2877.

    (收稿日期:2011-11-29)

您现在查看是摘要介绍页,详见PDF附件(3574kb)